HAVCR2 and hepatocellular carcinoma: However, in Hepa1-6 tumors, 32-134D inhibited the expression of the checkpoint ligands B7H4 and PDL1, and the checkpoint receptor TIM3, which are all associated with mortality in HCC (53).